<DOC>
	<DOCNO>NCT02967887</DOCNO>
	<brief_summary>This study ass efficacy safety hepatic arterial infusion cisplatin 5-fluorouracil ( HAIC ) advance HCC patient stratify biomarker expression predict therapeutic response .</brief_summary>
	<brief_title>Evaluation Hepatic Arterial Infusion Cisplatin 5-FU Biomarker Stratified HCC</brief_title>
	<detailed_description>Hepatic arterial infusion chemotherapy ( HAIC ) cisplatin 5-fluorouracil used advanced HCC . However , cisplatin 5-fluorouracil act cell without tumor selectivity . Therefore , improve tumor selectivity effectiveness HAIC , molecular subtyping-based stratification strategy consider . In study , patient progress intolerance sorafenib non-metastatic HCC TNM stage III-IVA ECOG PS 0 1 , Child-Pugh class A enrol . 96 patient pre-treatment tumor biopsy receive Cisplatin ( 60mg/m2 2h day 2 ) 5-fluorouracil ( 500mg/m2 5h day 1-3 ) implant port system . This treatment repeat every 4 week , 6 time . The primary objective determine overall response rate , benefit define complete partial response accord mRECIST V1.1 . Secondary endpoint include time progression , progression free survival . The biopsy tissue subject real time reverse transcriptase polymerase chain reaction quantification gene expression level . Patients categorize two group accord gene expression result , AUC value ROC curve analysis evaluate exploratory endpoint ass predictive performance biomarker therapeutic response HAIC .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>20 year old Patients advance hepatocellular carcinoma progress intolerance Sorafenib Patients advance hepatocellular carcinoma treat surgery , transplantation , RFA , TACE . TNM stage III/IV ( include intrahepatic single multiple tumor without extrahepatic metastasis regardless lymph node metastasis ) ECOG performance status 0 1 Liver function status ChildPugh Class A B 3 month life expectancy serum creatinine &lt; 1.5 mg/dL aminotransferase &lt; 5 time upper limit normal absolute neutrophil count &gt; 1,500 cells/lL platelet count &gt; 75,000/lL hemoglobin &gt; 10 g/d patient extrahepatic tumor Patients require combine treatment chemotherapy , radiotherapy , TACE , RFA , others Patients receive anticancer treatment ( except sorafenib ) within 8 week participate clinical trial Patients severe and/or uncontrolled medical condition Patients symptom suspect acute disease within 28 day drug administration Patients history cardiovascular , respiratory , renal , endocrine , hematologic , digestive , central nervous , psychiatric , malignant condition may affect absorption , distribution , metabolism excretion . Patients history peptic ulcer , inflammatory growth disease ( Crohn 's disease , ulcerative colitis ) , acute chronic pancreatitis , gastrointestinal surgery ( exclude simple cecal/hernia surgery ) Patients judge unfit subject health medical examination conduct within 28 day drug administration time screen , patient pulse rate per minute electrocardiogram â‰¤ 60 measure supine blood pressure thereafter 3 minute stand , patient whose blood pressure ( 20mmHg 10mmHg systolic diastolic ) drop If ALT / AST level exceed 1.25 time normal upper limit liver function test patient clinically significant allergic disease ( mild allergic rhinitis require medication ) patient participated subject clinical study ( date visit ) within 60 day drug administration Patients take medicine ( include herbal remedy ) within 14 day take test medicine general medicine within 7 day whose medication consider affect test affect safety subject judge investigator A person abnormal meal affect absorption , distribution , metabolism excretion drug ( eg , drink 1 L grapefruit juice day within 7 day drug administration ) A person donate whole blood within 60 day test drug donates ingredient blood within 30 day A person persistently intake Caffeine &gt; 5 cup / day ) , drink alcohol ( alcohol &gt; 30 g / day ) , abstain trial period heavy smoker ( cigarette &gt; 10 cfu / day ) Persons take herbal medicine St John 's Wort drug metabolize CYP3A4 enzyme increase inhibition production CYP enzymes within 30 day administration test drug ( itraconazole , ketoconazole , erythromycin , clarithromycin , Telithromycin , HIV protease inhibitor , etc . ) If creatinine clearance calculate CockroftGault formula &lt; 50 mL / min Bilateral renal artery stenosis , renal artery stenosis single kidney , renal transplantation , renal function alone Hypomagnesemia , hyponatremia , hypokalemia , hypercalcemia Addison 's disease patient Any person deem inappropriate reason investigator reason</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>